AGBA Acquisition (AGBAW) has had the highest return since January 1, 2024 by a US stock, returning 4,316.4%.
ASSET | % RETURN |
---|---|
AGBA Acquisition (AGBAW) | 4,316.39% |
Nexalin Technology (NXLIW) | 1,590.14% |
Palladyne AI (PDYNW) | 999% |
Codere Online Luxembourg SA Warrants (CDROW) | 819.38% |
LENZ Therapeutics (LENZ) | 762.58% |
Spectaire (SPECW) | 741.67% |
AdTheorent (ADTHW) | 714.14% |
Fitell Corporation Ordinary Shares (FTEL) | 713.82% |
Armada Acquisition Corp I Warrant (AACIW) | 700% |
GeneDx (WGS) | 668.52% |
AGBA Acquisition (AGBA) | 666.23% |
Janone (JAN) | 622.52% |
Corbus Pharmaceuticals (CRBP) | 615.31% |
Binah Capital Group, Inc Warrants (BCGWW) | 592.17% |
Inception Growth Acquisition Limited Warrants (IGTAW) | 564.47% |
Solowin Holdings Ordinary Share (SWIN) | 553.24% |
Biofrontera Inc Warrants (BFRIW) | 550% |
Liberty Resources Acquisition Corp Warrant (LIBYW) | 542% |
Swvl (SWVL) | 533.75% |
PHP Ventures Acquisition Corp Warrants (PPHPW) | 530% |
Candel Therapeutics (CADL) | 525.5% |
SoundHound AI (SOUNW) | 521.21% |
Bone Biologics Corp Warrants (BBLGW) | 515.8% |
Root (ROOT) | 512.86% |
Elevation Oncology (ELEV) | 507.41% |